Glenorchy Capital Ltd Invests $1.70 Million in Nutrien Ltd. (NYSE:NTR)

Glenorchy Capital Ltd purchased a new position in Nutrien Ltd. (NYSE:NTRFree Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 30,210 shares of the company’s stock, valued at approximately $1,702,000. Nutrien accounts for 0.7% of Glenorchy Capital Ltd’s portfolio, making the stock its 29th biggest position.

Other hedge funds have also recently modified their holdings of the company. GHP Investment Advisors Inc. purchased a new stake in shares of Nutrien in the 3rd quarter worth approximately $27,000. Legacy Financial Group LLC purchased a new stake in Nutrien during the third quarter valued at approximately $28,000. Exchange Traded Concepts LLC lifted its position in Nutrien by 904.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 753 shares of the company’s stock valued at $42,000 after acquiring an additional 678 shares during the last quarter. CVA Family Office LLC purchased a new stake in Nutrien during the fourth quarter valued at approximately $57,000. Finally, NBC Securities Inc. purchased a new stake in Nutrien during the third quarter valued at approximately $58,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

NTR traded down $0.03 during midday trading on Tuesday, hitting $52.27. 1,439,120 shares of the company traded hands, compared to its average volume of 2,013,353. The company has a current ratio of 1.17, a quick ratio of 0.65 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $25.85 billion, a price-to-earnings ratio of 20.66, a PEG ratio of 1.97 and a beta of 0.89. Nutrien Ltd. has a 52-week low of $47.90 and a 52-week high of $71.54. The business has a 50 day simple moving average of $53.10 and a two-hundred day simple moving average of $54.17.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings data on Wednesday, February 21st. The company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.72 by ($0.35). The company had revenue of $5.66 billion for the quarter, compared to analysts’ expectations of $5.36 billion. Nutrien had a net margin of 4.33% and a return on equity of 8.59%. The business’s revenue for the quarter was down 24.8% on a year-over-year basis. During the same period in the previous year, the business earned $2.02 earnings per share. On average, equities analysts forecast that Nutrien Ltd. will post 3.82 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, March 28th were paid a $0.54 dividend. This is an increase from Nutrien’s previous quarterly dividend of $0.53. This represents a $2.16 annualized dividend and a dividend yield of 4.13%. The ex-dividend date of this dividend was Wednesday, March 27th. Nutrien’s dividend payout ratio (DPR) is currently 85.38%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Wolfe Research assumed coverage on shares of Nutrien in a research report on Friday, March 1st. They set an “outperform” rating and a $66.00 target price for the company. JPMorgan Chase & Co. cut shares of Nutrien from a “neutral” rating to an “underweight” rating and decreased their target price for the company from $58.00 to $48.00 in a research report on Friday, February 23rd. Stifel Nicolaus increased their target price on shares of Nutrien from $72.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, January 19th. CIBC decreased their target price on shares of Nutrien from $87.00 to $76.00 and set an “outperform” rating for the company in a research report on Friday, February 23rd. Finally, BMO Capital Markets cut their price target on shares of Nutrien from $86.00 to $80.00 and set an “outperform” rating on the stock in a research note on Thursday, January 25th. Two analysts have rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, Nutrien currently has an average rating of “Hold” and a consensus target price of $67.95.

Check Out Our Latest Research Report on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.